A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice

A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice

Aim: This study developed and validated a non-invasive scoring model to predict 1-year hepatitis B e antigen (HBeAg) seroconversion in response to nucleos(t)ide analog (NA) treatment in NA-naïve patients with HBeAg-positive chronic hepatitis B (CHB). Methods: Baseline data from 1014 patients visitin...

Full description

Bibliographic Details
Main Authors: Mingfan Geng, Yuxin Li, Fangyuan Gao, Le Sun, Xue Yang, Rui Wang, Jialiang Chen, Qun Zhang, Gang Wan, Xianbo Wang
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:International Journal of Infectious Diseases
Subjects:
Chronic hepatitis B
HBeAg seroconversion
Nucleos(t)ide analogs
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971217301704

Internet

http://www.sciencedirect.com/science/article/pii/S1201971217301704

Similar Items